Table: begin end state 1 26 cytoplasmic 27 47 transmembrane 48 53 non-cytoplasmic 54 73 transmembrane 74 106 cytoplasmic 107 129 transmembrane 130 134 non-cytoplasmic 135 153 transmembrane 154 163 cytoplasmic 164 186 transmembrane 187 206 non-cytoplasmic 207 229 transmembrane 230 249 cytoplasmic 250 270 transmembrane 271 290 non-cytoplasmic 291 313 transmembrane 314 344 cytoplasmic 345 362 transmembrane 363 367 non-cytoplasmic 368 389 transmembrane 390 409 cytoplasmic 410 432 transmembrane 433 437 non-cytoplasmic 438 457 transmembrane 458 473 cytoplasmic
Input: >AO356_17670 MPVGNHLPHGETAQGGPLKRELGERHIRLMALGACIGVGLFLGSAKAIEMAGPAIMLSYI IGGLAILVIMRALGEMAVHNPVAGSFSRYAQDYLGPLAGFLTGWNYWFLWLVTCVAEITA VAVYMGIWFPDVPRWIWALAALVSMGSINLIAVKAFGEFEFWFALIKIVTIIAMVIGGVG IIAFGFGNDGVALGISNLWAHGGFMPNGVSGVLMSLQMVMFAYLGVEMIGLTAGEAKNPQ KTIPNAIGSVFWRILLFYVGALFVILSIYPWNEIGTQGSPFVMTFERLGIKTAAGIINFV VITAALSSCNGGIFSTGRMLYSLAQNGQAPAGFAKTSTNGVPRRALLLSIAALLLGVLLN YLVPEKVFVWVTSIATFGAIWTWVMILLAQLKFRKSLSASERAALKYRMWLYPVSSYLAL AFLVLVVGLMAYFPDTRVALYVGPAFLVLLTVLFYTFKLQPTGDVQRAVRSAS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server